Drug Shortage Report for NALOXONE HYDROCHLORIDE INJECTION USP

Last updated on 2025-04-21 History
Report ID 210664
Drug Identification Number 02382482
Brand name NALOXONE HYDROCHLORIDE INJECTION USP
Common or Proper name NALOXONE HYDROCHLORIDE INJECTION USP
Company Name HIKMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) NALOXONE HYDROCHLORIDE
Strength(s) 0.4MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 1mL
ATC code V03AB
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2023-11-17
Actual start date
Estimated end date 2025-06-30
Actual end date
Shortage status Actual shortage
Updated date 2025-04-21
Company comments Hikma NALOXONE INJECTABLE (DIN 02458578, product code 0141AA01) available in same size ampoule and strength.
Health Canada comments
Tier 3 Status No
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v19 2025-04-21 French Compare
v18 2025-04-21 English Compare
v17 2024-12-19 French Compare
v16 2024-12-19 English Compare
v15 2024-12-19 French Compare
v14 2024-12-19 English Compare
v13 2024-12-19 English Compare
v12 2024-06-26 French Compare
v11 2024-06-26 English Compare
v10 2024-06-26 English Compare
v9 2024-05-13 French Compare
v8 2024-05-13 English Compare
v7 2024-04-09 French Compare
v6 2024-04-09 English Compare
v5 2024-03-01 French Compare
v4 2024-03-01 English Compare
v3 2023-11-18 English Compare
v2 2023-11-17 French Compare
v1 2023-11-17 English Compare

Showing 1 to 19 of 19